ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
21 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
40
|
13K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
adreamer
|
100 |
29K |
9 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
100
|
29K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
14 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
40
|
13K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
14 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
40
|
13K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
4 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
40
|
13K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Walk to Defeat MND
|
|
adreamer
|
40 |
13K |
28 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
40
|
13K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
36 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
9 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
adreamer
|
77 |
21K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
77
|
21K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Allan Border
|
|
adreamer
|
12 |
2.9K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
12
|
2.9K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
adreamer
|
77 |
21K |
12 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
21K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
adreamer
|
77 |
21K |
16 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
21K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
adreamer
|
77 |
21K |
20 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
21K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
14 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
18 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
55
|
16K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
17 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.4K
|
385K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
23 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
55
|
16K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
16K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
11 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
55
|
16K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
adreamer
|
66 |
19K |
7 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
66
|
19K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
adreamer
|
31 |
12K |
15 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
31
|
12K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
adreamer
|
62 |
18K |
28 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
62
|
18K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
16K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
adreamer
|
222 |
52K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
222
|
52K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
adreamer
|
62 |
18K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
18K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
10 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
16K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
13 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
2 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
16K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
adreamer
|
55 |
16K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
55
|
16K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Media clarification
|
|
adreamer
|
62 |
18K |
8 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
62
|
18K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
adreamer
|
31 |
12K |
21 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
12K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
adreamer
|
63 |
21K |
9 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
63
|
21K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
adreamer
|
31 |
12K |
17 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
31
|
12K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
adreamer
|
317 |
86K |
32 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
317
|
86K
|
32
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.4K |
385K |
27 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.4K
|
385K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
adreamer
|
297 |
86K |
17 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
297
|
86K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
adreamer
|
33 |
9.4K |
16 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
33
|
9.4K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
126
|
34K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
21 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
126
|
34K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
8 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
34K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
13 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
126
|
34K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
6 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
126
|
34K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
8 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
34K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
adreamer
|
126 |
34K |
18 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
126
|
34K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
adreamer
|
317 |
86K |
34 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
317
|
86K
|
34
|
|
ASX - By Stock
|
PAA |
Re:
what odds of house deposit
|
|
adreamer
|
14 |
3.9K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
14
|
3.9K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
adreamer
|
222 |
52K |
9 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
222
|
52K
|
9
|
|